News
GlobalData on MSN2mon
Blue Earth’s radioligand therapy achieves high tumour radiation absorptionBlue Earth Therapeutics’s injectable investigational radioligand therapy, Lutetium rhPSMA-10.1, has led to higher doses of ...
myQA Blue Phantom³ is designed for fast and high ... This launch underscores IBA's commitment in advancing quality and precision of radiation therapy delivery and thereby enhancing patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback